Product Description: EGFR/HER2-IN-13 (Compd 38) is an inhibitor of mutant EGFR/HER2s which are resistant to other drugs. EGFR/HER2-IN-13 can be used for cancer research[1].
Applications: Cancer-Kinase/protease
Formula: C27H36N8O3
References: [1]John H, et al. Inhibitors of egfr or her2 and methods of use. WO2024073745A1. 2024-04-04